Disordered Hemostasis and Renal Disorders
Pediatric Kidney Disease, Page: 877-901
2023
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Book Chapter Description
Renal disorders can impact the balance of hemostasis and result in predispositions to either bleeding or thrombosis. This delicate balance is influenced by normal physiologic changes to coagulation, known as developmental hemostasis, that need to be taken into consideration when assessing and treating children with kidney diseases. This chapter reviews the main developmental hemostasis changes that occur during childhood. Furthermore, the two sides of hemostasis are then described in detail, including conditions associated with bleeding (uremic coagulopathy) and thromboses (nephrotic syndrome, renal vascular thromboses, renal transplantation, and hemolytic uremic syndrome). Treatment recommendations are provided based on best evidence and standards, with updated information on clinical guidelines and use of new oral anticoagulant agents.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85207229526&origin=inward; http://dx.doi.org/10.1007/978-3-031-11665-0_33; https://link.springer.com/10.1007/978-3-031-11665-0_33; https://dx.doi.org/10.1007/978-3-031-11665-0_33; https://link.springer.com/chapter/10.1007/978-3-031-11665-0_33
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know